Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The lipedema common case report form as a research tool: standardizing lipedema data collection.

Frontiers in global women's health·2026
Same author

Epitranscriptomic circuits wiring the tumor microenvironment: A pharmacodynamic framework for clinical translation.

Pharmacological research·2026
Same author

Evolving Landscape of Glioblastoma Research: Integrating Therapeutic Advances and Diagnostic Frontiers.

Brain sciences·2026
Same author

GD2 Identifies Cancer Stemness in Glioblastoma and Phytoalexin Library Screen Identifies Potential Novel Natural Inhibitors.

International journal of molecular sciences·2026
Same author

Targeting TRAF3IP2 disrupts cellular energetics through inhibition of NAMPT in triple negative breast cancer.

Scientific reports·2025
Same author

Editorial: Role of induced pluripotent stem cells (iPSCs) in regenerative medicine, disease modeling and drug discovery.

Frontiers in bioengineering and biotechnology·2025

Related Experiment Video

Updated: Jul 6, 2026

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
07:45

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Gene delivery to mesenchymal stem cells.

Reza Izadpanah1, Bruce A Bunnell

  • 1Center for Gene Therapy, Tulane University Health Sciences Center, New Orleans, LA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
PubMed
Summary

Gene therapy requires effective delivery to target cells. Mesenchymal stem cells (MSCs) are ideal for gene delivery due to their differentiation potential and ability to maintain transgene expression for tissue engineering applications.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Gene therapy success hinges on efficient delivery to target cells.
  • Mesenchymal stem cells (MSCs) are promising for tissue engineering due to their differentiation capabilities.
  • Autologous stem cell-based delivery offers a targeted therapeutic strategy.

Purpose of the Study:

  • To describe methods for gene delivery to mesenchymal stem cells (MSCs).
  • To highlight MSCs as valuable targets for gene therapy and tissue engineering.

Main Methods:

  • Transduction of MSCs with integrating vectors.
  • Utilizing MSCs' high amphotropic receptor levels for efficient gene uptake.
  • Maintaining transgene expression in vitro and in vivo.

More Related Videos

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Related Experiment Videos

Last Updated: Jul 6, 2026

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
07:45

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Main Results:

  • MSCs are readily transduced with integrating vectors.
  • Transgene expression is maintained in MSCs without affecting multipotentiality.
  • MSCs demonstrate potential for cell-based gene delivery.

Conclusions:

  • Mesenchymal stem cells are highly suitable targets for gene therapy.
  • The described methods facilitate gene delivery to MSCs for therapeutic applications.
  • MSCs are poised to be crucial cytoreagents in future gene therapy strategies.